COMBINATION FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS AND PROLIFERATIVE SKIN DISEASES

摘要

The invention features a method for treating a patient who has an immunoinflammatory disorder or a proliferative skin disease, or is at risk for developing an immunoinflammatory disorder or a proliferative skin disease, by administering to the patient a prostaglandin and a retinoid simultaneously or within 14 days of each other in amounts sufficient to reduce or inhibit immunoinflammatory or dermal/epidermal proliferation.